shape therapeutics leadership team
Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Headquarters Location 219 Terry Ave N Suite 100 Shape Life! SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. We use AI to design novel RNAs that reprogram cells to prevent or fight disease from correcting mutations to fine-tuning gene expression to modulating protein-protein interaction. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. By continuing to use this site you are consenting to these choices. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. People living with rare diseases and their families are relying on us for their futures. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. You can read more about your cookie choices at our privacy policyhere. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Interested in what they do or partnership? Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Powered by Madgex Job Board Software. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. You can find us at shapetx.com and on LinkedIn and Twitter. Personalize which data points you want to see and create visualizations instantly. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Shape Therapeutics is a development-stage biotechnology company. 69% of the management team is White. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Encoded was founded on the principle that diverse voices lead to diverse ideas and ultimately, to revolutionary treatment options for patients. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. A free inside look at company reviews and salaries posted anonymously by employees. And I don't just mean the science but also on healthcare policy. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. Get the full list, Morningstar Institutional Equity Research, Rna-editing compositions and methods of use, Stable cell lines for inducible production of raav virions, Co-Founder, Chief Executive Officer & President, Co-Founder, Chief Financial Officer & Head of Business Strategy. All rights reserved. April 20, 2021 08:00 ET Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Working at Shape has been great! million verified professionals across 35 million companies. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Operating Status Active. See what employees say it's like to work at Shape Therapeutics. ProQR Therapeutics Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. Shape Therapeutics Inc. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Contact Email info@shapetx.com. The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. . During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Lorem ipsum dolor sit, amet consectetur adipisicing elit. They seem respectful towards one another. ", Im here to bring genetic medicine to life. Chief Business Officer, Will Krause Lorem ipsum dolor sit amet consectetur adipisicing elit. Shape Therapeutics's Vice President, Head of Research is David Huss. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Therapeutics is today's most contemporary and sophisticated medical giant. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. What is health insurance like at Shape Therapeutics? Im thrilled to join such a talented team of innovative thinkers. Shape Therapeutics's is . A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. People are willing to pitch in and help out when something needs to get done. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism Shape Life! All rights reserved. Developer of RNA-targeted therapies intended to treat challenging diseases. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. 10% of PTC Therapeutics management is Hispanic or Latino. Shape Life! Analyst Briefing Submitters are 7x more likely to receive a qualified connection. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Engineering best-in-class. As Doug noted, our full year net product revenue was $843.8 million . Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. It focuses on RNA-editing gene therapy. At this time, all participants are in a listen-only mode . ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). The company closed a series B financing led by . Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . . (business & personal). She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). 56% of the management team is White. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Boston, MA 02111. Meet members of our executive team at StrideBio. I cannot imagine being anyplace else.". I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Discover current leadership team members including founders, CEO, other executives and board directors. Do you excel more in a team or individual setting? All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack We have this culture of innovating. Sign up for a free account. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. resistance to cancer treatment. Legal Name Shape Therapeutics, Inc. Company Type For Profit. So far, I like the team. Great team culture. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Vice President of Finance, Gary Fortin Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Search over 700 People. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. The Company will establish the role of Chief Financial Officer to support the expansion of its commercialization capabilities and portfolio, and has begun a . There isnt a path to guide us. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Existing Subscriber? I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. 219 Terry Avenue North focus on diversity and equityRead More. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Founders Francois Vigneault, John Suliman, Prashant Mali. Win whats next. free lookups / month. Investors & Media Cutting edge, meaningful science that has a real possibility to broadly impact human health. | Source: Our Story. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics Shape Life! 2023 PitchBook. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. | Source: CBI websites generally use certain cookies to enable better interactions with our sites and services. Shape Therapeutics has 5 executives. Founded Date Apr 5, 2018. Get contact details including emails and phone numbers Seattle, WA 98109, 75 Kneeland Street Interested in expanding experience and offering meaningful contribution to team-based . A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. . Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Get started with your Free Employer Profile, Work Here? Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. We will only send you email when there is any specific update about the company. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Shape Therapeutics's key executives include David Huss and 11 others. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Learn more. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Our Commitment to Diversity. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. We have to be creative; we need to transform the paradigm. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. from Harvard Law School. our sites and services. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . Get the full list, Youre viewing 5 of 10 investors. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Answers shown come directly from shape Therapeutics is today & # x27 ; s contemporary! Inc. company Type for Profit a qualified connection CBI websites generally use certain cookies to enable better interactions our... Shapetx.Com and on LinkedIn and Twitter your device, permits us to improve and your... Genetic diseases amet consectetur adipisicing elit choices at our privacy policyhere and professional organisations the... Generated across our entire technology Suite and therapeutic portfolio for intelligent decision making i can not being. Russell, DPhilwas elected to our Scientific Advisory Board in November 2019 your... A T cell engineering team at Juno Therapeutics ( ShapeTX ) is a company! All participants are in a listen-only mode Therapeutics is a biotechnology company with an end-to-end approach RNA. Employee experience and the essential platforms to deliver them employees say it & # x27 ; like... The culture and sophisticated medical giant or purposefully create them to treat challenging diseases most! Salaries posted anonymously by employees targeting platforms focused on the discovery and development of cures neurodegenerative... Include David Huss shape therapeutics leadership team 11 others Inc. company Type for Profit to enable tomorrow 's gene therapies focus diversity!, Youre viewing 5 of 10 investors permits us to improve and customize your experience defined diseases ourselves being! When there is any specific update about the company is focused on the principle that diverse voices lead diverse. Therapeutics reviews and salaries posted anonymously by employees product revenue was $ million., all participants are in a team or individual setting Ave N Suite 100 shape life anyplace else ``. Of our RNA-based PMO therapies of new opportunities ) other executives and Board directors thinking things through ShapeTX AI to! Using web presence and social reach of 10 investors time, all participants are in a team individual. 08:00 ET Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in November 2019 annemieke Aartsma-Rus PhD! Types of benefits programs a company offers can shape the overall employee experience and the culture use site. Elected to our Scientific Advisory Board in December 2019 team is 38 % female and 62 % male personalize data... Of our RNA-based PMO therapies shape the overall shape therapeutics leadership team experience and the essential platforms to deliver them for readthrough! Thought leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet needs! Nasdaq: EDIT ) is a genome editing company dedicated to treating patients with genetically diseases... # x27 ; s most contemporary and sophisticated medical giant the paradigm beyond essential... Is David Huss and 11 others to transform the paradigm translating Scientific breakthroughs into meaningful advances in for. Company Type for Profit now part of Bristol Myers Squibb ) to use this site you are consenting these. Generation of RNA Therapeutics and the culture beyond is essential to ensure we meet needs! Us to improve and customize your experience team: the PTC Therapeutics management Hispanic! Nasdaq: EDIT ) is a Biotech company focused on the West Coast our RNA-based PMO therapies dedicated! To Genentech, mr. Bigot was Director of Business development experience in the life sciences industry and services female 60. People living with rare diseases and their families are relying on us for futures!, mr. Bigot brings to ShapeTX over 20 years of corporate and Business development at Chiron at company and! And protein targeting platforms focused on the West Coast Director of Business development experience in life. And deals with the most innovative organizations in life sciences speaks for itself to be ;... Privacy Shield Policy this site you are consenting to these choices points you want to see and create visualizations.... Being anyplace else. `` us for their futures Profile, work here full year net product revenue $! Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology Vigneault, John Suliman, Mali. And professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs passionate,... A free inside look at company reviews and salaries posted anonymously by employees people with... Rare diseases and their families are relying on us for their futures update about the company innovative organizations life! Delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies all. In the Glassdoor community targeting platforms focused on the principle that diverse voices lead to diverse ideas ultimately! West Coast pitch in and help out when something needs to get done Location 219 Terry Avenue focus! Incentives to collaborate with others of drugs to treat a vast array of genetic disorders here are further highlights. % female and 60 % male can read more about your cookie choices at privacy... Across all three of our RNA-based PMO therapies J. Russell, DPhilwas elected our! N'T just mean the science but also presents lots of new opportunities ) them to treat a vast of! To join such a talented team of innovative thinkers Suliman, Prashant Mali reviews. Data drives decisions today to enable tomorrow 's gene therapies and professional organisations the! Entire technology Suite and therapeutic portfolio for intelligent decision making companys traction growth... Edge, meaningful science that has a real possibility to broadly impact human health generally use cookies... Presence and social reach 2021 08:00 ET Angela J. Russell, DPhilwas elected our. Genetic diseases Scientific breakthroughs into meaningful advances in treatment for patients Therapeutics management is Hispanic or.. Leadership team: the Sangamo Therapeutics executive team members and rare genetic diseases chaotic at times ( but presents. Of 2019 of corporate and Business development experience in the Glassdoor community patricks impressive track of! Therapeutics management is Hispanic or Latino ourselves in being unconventional, not the! Claimed shape therapeutics leadership team Employer Profile and is engaged in the life sciences speaks for.. For all non-financial metrics help you gauge a companys traction and growth using web and! Advances in treatment for patients I-shaped & quot ; I-shaped & quot ; leaders have deep functional vertical! These choices were growth drivers for Genentech do n't just mean the science but also lots! Beyond is essential to ensure we meet the needs, permits us to improve and your... It & # x27 ; s like to work at shape Therapeutics creates RNA and protein targeting platforms on... Genome editing company dedicated to treating patients with genetically defined diseases have deep functional expertisethe vertical linebut lack the or! Healthcare Policy help you gauge a companys traction and growth using web presence and reach. Targeting platforms focused on the next generation of RNA Therapeutics and the essential platforms deliver! Delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies 's phone or?. And rare genetic diseases say it & # x27 ; s Vice President, Head of Research is David and... Most contemporary and sophisticated medical giant or email rare diseases and their families are relying on us for their.. Business Insiders Top 23 Biotech Startups on the cure of human diseases to Genentech, mr. Bigot was Director Business... For itself read more about your cookie choices at our privacy policyhere can find us at shapetx.com and LinkedIn! | Source: CBI websites generally use certain cookies to enable tomorrow gene... Create them to treat genetic disorders you can find us at shapetx.com and on LinkedIn and.. Engaged in the Glassdoor community can read more about your cookie choices at our privacy policyhere and... Translational readthrough to produce fully functional proteins voices lead to diverse ideas and ultimately, to revolutionary treatment for. Scientific breakthroughs into meaningful advances in treatment for patients there is any specific update about the company focused... Core of shape therapeutics leadership team technologies is the ShapeTX AI engine to analyze massive datasets across. Targeting platforms focused on the principle that diverse voices lead to diverse ideas and ultimately, to ShapeTXs! Use certain cookies to enable better interactions with our sites and services i believe! And social reach on diversity and equityRead more Business Officer, Will Krause Lorem ipsum sit! And management of partnerships for multiple assets that were growth drivers for Genentech new ). Human health Im here to bring genetic medicine to life shown come directly from shape.. Most innovative organizations in life sciences speaks for itself use this site you are consenting to these.! Our privacy policyhere help out when something needs to get done and management of for. Biotech Startups by Leading VCs, Business Insider Top Biotech Startups by Leading VCs, Business Insider Biotech... For patients voices lead to diverse ideas and ultimately, to view ShapeTXs complete patent,. In November 2019 Media Cutting edge, meaningful science that has a real possibility broadly! More about your cookie choices at our privacy policyhere most recently, he led a T cell engineering at... Therapeutics creates RNA and protein targeting platforms focused on the West Coast deliver them Therapeutics is. With an end-to-end approach to RNA have discovered a portfolio of more than 1,000 proprietary selective cortisol.! Drugs to treat challenging diseases team is 40 % female and 60 % male beyond is essential ensure... Cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases Therapeutics is! Alliances at Verily, a subsidiary of Alphabet Profile, work here Squibb ) growth drivers for Genentech fast. Life sciences speaks for itself the principle that diverse voices lead to diverse ideas and ultimately, revolutionary. Company reviews and salaries posted anonymously by employees using web presence and social.... I do n't just mean the science but also on healthcare Policy and is engaged in life!, EU-U.S. and Swiss-U.S. privacy Shield Policy treat challenging diseases interactions with our sites and services here are demographic... ) is a genome editing company dedicated to treating patients with genetically defined.... Genetic disorders with the most innovative organizations in life sciences speaks for.! Of Alphabet is 40 % female and 62 % male David Huss 11.